Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “anti-”

1,068 pharma patents match "anti-" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,068
Index total 30,257
Page 35 / 45

Quick answer

This filtered view shows 1,068 pharmaceutical patents matching "anti-" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,068 results for “anti-” · 30,257 patents in full index Clear search

  1. US 8901171

    Compounds for suppressing a peripheral nerve disorder induced by an anti-cancer agent

    Takeda Pharmaceutical Company Limited · Granted Dec 2, 2014 · Expires Nov 27, 2034

    granted

  2. US 8889138

    Anti-ADDL antibodies and uses thereof

    Northwestern University · Granted Nov 18, 2014 · Expires Nov 13, 2034

    granted

  3. US 8883500

    Method of preparing adenosine-resistant anti-tumor T lymphocytes for adoptive immunotherapy

    Northwestern University · Granted Nov 11, 2014 · Expires Nov 6, 2034

    granted

  4. US 8871206

    Anti-human folate receptor beta antibodies and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 28, 2014 · Expires Oct 23, 2034

    granted

  5. US 8865175

    Increasing anti-IL-1α antibodies in a subject

    XBIOTECH INC. · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted

  6. US 8859512

    Anti-viral pyrimidine nucleoside derivatives

    University College Cardiff Consultants Limited · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted

  7. US 8858946

    Method for inhibiting HIV-1 replication utilizing anti-GBV-C E2 antibodies

    THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF VETERANS AFFAIRS · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted

  8. US 8853247

    Oligomer-nitroimidazole anti-infective conjugates

    Nektar Therapeutics · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted

  9. US 8846056

    Anti-RSV immunogens and methods of immunization

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

  10. US 8846034

    Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof

    HALOZYME, INC. · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

  11. US 8841273

    Methods and compositions for anti-EGFR treatment

    The Board of Regents of the University of Texas System · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted

  12. US 8834883

    Anti-VEGF antibodies and uses thereof

    VACCINEX, INC. · Granted Sep 16, 2014 · Expires Sep 11, 2034

    granted

  13. US 8835613

    β-mannosylceramide and stimulation of NKT cell anti-tumor immunity

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 16, 2014 · Expires Sep 11, 2034

    granted

  14. US 8835167

    Humanized anti-tag 72 CC49 for diagnosis and therapy of human tumors

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 16, 2014 · Expires Sep 11, 2034

    granted

  15. US 8829025

    Anti-cancer compounds

    Northwestern University · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  16. US 8822196

    Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted

  17. US 8816058

    Polynucleotides encoding anti-CD100 antibodies or antigen-binding fragments thereof

    VACCINEX, INC. · Granted Aug 26, 2014 · Expires Aug 21, 2034

    granted

  18. US 8809502

    Mutated anti-CD22 antibodies with increased affinity to CD22-expressing leukemia cells

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted

  19. US 8809341

    2,4-pyrimidinediamine compounds and uses as anti-proliferative agents

    Rigel Pharmaceuticals, Inc. · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted

  20. US 8802656

    Purified phospholipid-non-steroidal anti-inflammatory drug associated compositions and methods for preparing and using same

    The Board of Regents of the University of Texas System · Granted Aug 12, 2014 · Expires Aug 7, 2034

    granted

  21. US 8795656

    Methods of treating rheumatoid arthritis by administering an anti-IL3 antibody

    Klinikum der Universität Regensburg · Granted Aug 5, 2014 · Expires Jul 31, 2034

    granted

  22. US 8796209

    Compositions and methods related to anti-FGF agents

    The Regents of the University of California · Granted Aug 5, 2014 · Expires Jul 31, 2034

    granted

  23. US 8795669

    Stabilized formulations containing anti-PCSK9 antibodies

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 5, 2014 · Expires Jul 31, 2034

    granted

  24. US 8791244

    Anti-ErbB3 antibodies and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Jul 29, 2014 · Expires Jul 24, 2034

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.